Trajectory of COVID-related tinnitus over the pandemic timeline

OBJECTIVES: COVID-19 is a respiratory disease caused by the coronavirus SARS-CoV-2. Previous studies reported cases of tinnitus following COVID infection, most of them mild and with similar characteristics to other forms of tinnitus. Our aim is to further explore the relationship between COVID-19 and tinnitus. For this purpose, we analyzed people in our city after a COVID-19 infection. METHOD: 233 patients over 18-years old and previously confirmed diagnosis of COVID-19 confirmed by either a RT-PCR, antibodies or antigens test were included. Patients were subdivided in three groups: No Tinnitus (NT), tinnitus that already existed before COVID-19 (Chronic Tinnitus, CT) and tinnitus that arose during or after COVID-19 (Post-COVID-19 Tinnitus, PCT). Data concerning COVID-19 symptoms, drugs prescribed for COVID-19, tinnitus characteristics, comorbidities and other otological symptoms were collected. Tinnitus assessment included pure tone audiograms, the Tinnitus Handicap Inventory, visual-analog scales for loudness and distress as well as the hospital anxiety and depression scale. Patients with CT were additionally asked whether their tinnitus worsened after their COVID-19 infection. RESULTS: No statistical difference was found between CT and PCT concerning hearing, tinnitus characteristics and tinnitus distress. There was also no statistically significant difference between PCT and NT with respect to COVID-19 symptoms and pharmacological COVID-19 treatment. Only 7% of the patients with CT reported worsening of their tinnitus after COVID-19. There was a decrease on post-COVID cases along the pandemic's timeline: 9.8% in 2020, 6.7% in 2021, 4.4% in 2022 and 0% in 2023 and 2024 (p = 0.058). CONCLUSION: Our data demonstrated that PCT tinnitus is very similar to other forms of tinnitus and generally mild. Also, PCT cases decreased along the pandemic's timeline, possibly due to the onset of vaccination, emergence of omicron as the dominant variant and improvement on the psychological aspects related to the pandemics. EVIDENCE LEVEL: 3b.

Authors

Institutions

Publication Details

Journal
Brazilian Journal of Otorhinolaryngology
Published
2026-06-16
DOI
https://doi.org/10.1016/j.bjorl.2026.101857
Primary Topic
Hearing, Cochlea, Tinnitus, Genetics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trajectory of COVID-related tinnitus over the pandemic timeline

Norma de Oliveira Penido, Berthold Langguth, Ricardo Rodrigues Figueiredo, Guilherme De Mesquita Rodrigues Figueiredo et al.
Brazilian Journal of Otorhinolaryngology
Hearing, Cochlea, Tinnitus, Genetics
article

Trajectory of COVID-related tinnitus over the pandemic timeline

Norma de Oliveira Penido, Berthold Langguth, Ricardo Rodrigues Figueiredo, Guilherme De Mesquita Rodrigues Figueiredo, Andréia A. de Azevedo
article en

Abstract

OBJECTIVES: COVID-19 is a respiratory disease caused by the coronavirus SARS-CoV-2. Previous studies reported cases of tinnitus following COVID infection, most of them mild and with similar characteristics to other forms of tinnitus. Our aim is to further explore the relationship between COVID-19 and tinnitus. For this purpose, we analyzed people in our city after a COVID-19 infection. METHOD: 233 patients over 18-years old and previously confirmed diagnosis of COVID-19 confirmed by either a RT-PCR, antibodies or antigens test were included. Patients were subdivided in three groups: No Tinnitus (NT), tinnitus that already existed before COVID-19 (Chronic Tinnitus, CT) and tinnitus that arose during or after COVID-19 (Post-COVID-19 Tinnitus, PCT). Data concerning COVID-19 symptoms, drugs prescribed for COVID-19, tinnitus characteristics, comorbidities and other otological symptoms were collected. Tinnitus assessment included pure tone audiograms, the Tinnitus Handicap Inventory, visual-analog scales for loudness and distress as well as the hospital anxiety and depression scale. Patients with CT were additionally asked whether their tinnitus worsened after their COVID-19 infection. RESULTS: No statistical difference was found between CT and PCT concerning hearing, tinnitus characteristics and tinnitus distress. There was also no statistically significant difference between PCT and NT with respect to COVID-19 symptoms and pharmacological COVID-19 treatment. Only 7% of the patients with CT reported worsening of their tinnitus after COVID-19. There was a decrease on post-COVID cases along the pandemic's timeline: 9.8% in 2020, 6.7% in 2021, 4.4% in 2022 and 0% in 2023 and 2024 (p = 0.058). CONCLUSION: Our data demonstrated that PCT tinnitus is very similar to other forms of tinnitus and generally mild. Also, PCT cases decreased along the pandemic's timeline, possibly due to the onset of vaccination, emergence of omicron as the dominant variant and improvement on the psychological aspects related to the pandemics. EVIDENCE LEVEL: 3b.

Brazilian Journal of OtorhinolaryngologyVol. 92(5)
Sociedade Brasileira de Cirurgia de Cabeça e Pescoço (BR), Centro Universitário de Volta Redonda (BR), Fundação Educacional D. André Arcoverde (BR), Fundação Otorrinolaringologia (BR), University of Regensburg (DE), Universidade Federal de São Paulo (BR)
Good health and well-being
Openalex Percentile: Top 7%
Hearing, Cochlea, Tinnitus, Genetics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.